"Ace Cardiopathy Sells 60% Stake to Entero Healthcare to Drive Growth in Cardiovascular Solutions"

"Ace Cardiopathy Solutions is selling 60% of its shares to Entero Healthcare for ₹59.30 Crore to ₹77.10 Crore, subject to adjustments. The acquisition aims to boost Ace Cardiopathy's growth by utilizing Entero Healthcare's distribution network, while strengthening Entero Healthcare's position in the cardiovascular health equipment sector. Obhan & Associates provided legal advisory for the transaction."

Obhan & Associates advised Ace Cardiopathy Solutions Private Limited in its transaction involving the sale of 60% of its shareholding to Entero Healthcare Solutions Limited. The transaction, valued between ₹59.30 Crore to ₹77.10 Crore (subject to adjustments for net debt, normalized working capital, and achievement of certain conditions), is expected to accelerate Ace Cardiopathy's growth by leveraging Entero Healthcare's established distribution network and market reach. For Entero Healthcare, the acquisition strengthens its position in the healthcare and life sciences sector by incorporating Ace Cardiopathy's expertise in the distribution of cardiovascular health equipment. The transaction was led by a team from Obhan & Associates comprising Ashima Obhan (Senior Partner), Shuchi Dutta (Senior Associate), and Aakanksha Singh (Associate). The firm provided legal assistance on transaction structuring, drafting and negotiation of definitive agreements and ancillary documents, as well as support through closing and post-closing formalities.

"Ace Cardiopathy Sells 60% Stake to Entero Healthcare to Drive Growth in Cardiovascular Solutions"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads